Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Octreotide significantly reduces the need for blood transfusions and endoscopic procedures in patients suffering from angiodysplasia-related anemia. This study confirms its efficacy in managing this challenging gastrointestinal condition.
Area Of Science
- Gastroenterology
- Vascular Medicine
- Hematology
Background
- Gastrointestinal angiodysplasias are vascular malformations causing anemia, often resistant to endoscopic treatments.
- Previous meta-analyses suggested octreotide efficacy, but with high risk of bias.
- Clinical trials are needed to validate octreotide's role in reducing transfusion dependency.
Purpose Of The Study
- To evaluate the efficacy of octreotide in decreasing transfusion requirements for patients with angiodysplasia-related anemia.
- To compare octreotide long-acting release with standard of care in a randomized controlled trial setting.
Main Methods
- A multicenter, open-label, randomized controlled trial involving 62 patients.
- Patients received either 40-mg octreotide intramuscular injections every 28 days or standard of care for 1 year.
- Primary outcome: mean difference in transfusion units (red blood cell and iron) between groups, analyzed using ANCOVA.
Main Results
- Octreotide group (n=31) had 11.0 mean transfusions vs. 21.2 in standard care (n=31).
- Octreotide reduced mean transfusion units by 10.2 (P=.012) and endoscopic procedures by 0.9 annually.
- The treatment was effective in patients with significant transfusion needs prior to enrollment.
Conclusions
- Octreotide is an effective treatment for reducing transfusion requirements in angiodysplasia-related anemia.
- Octreotide therapy also decreases the need for repeat endoscopic interventions.
- This trial provides robust evidence for octreotide's benefit in managing this condition.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Vagotomy: This procedure aims to reduce gastric acid secretion by cutting a portion of the vagus nerve. While effective, its frequency has declined due to the availability of effective acid-suppressing medications. It may be performed with or...
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...